Physician profile
John Garton
NPI 1821094210
$303.36
in general payments reported to CMS, 2019-2025
9 companies · $24.78 in 2025
The $24.78 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.78 · 2020: $50.40 · 2021: $25.54 · 2022: $19.79 · 2024: $163 · 2025: $24.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175 · Education: $13.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.68 |
| Education | $13.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $113.39 | 2024 | Ellipsys Vascular Access System |
| Vifor Pharma, INC. | $68.82 | 2020-2022 | |
| Daiichi Sankyo INC. | $31.92 | 2024-2025 | Injectafer |
| Otsuka America Pharmaceutical, INC. | $19.78 | 2019 | |
| Baxter Healthcare | $14.82 | 2024 | Renal - Crrt |
| Xeris Pharmaceuticals, INC. | $14.55 | 2024 | Keveyis |
| Alexion Pharmaceuticals, INC. | $14.17 | 2021 | |
| Travere Therapeutics, INC. | $13.17 | 2024-2025 | Filspari |
| Mallinckrodt Hospital Products INC. | $12.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Garton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.